This test analyzes genetic variants in pathways that influence GLP-1 responsiveness (GLP1R rs6923761), GIP signaling (GIPR rs1800437), appetite regulation (MC4R rs17782313), and fat oxidation (FTO rs9939609)
Im a touch lighter than I should be, but the plan was always to come down a bit more, to go up a bit. Its not what Wegovy or Mounjaro were designed for which was to help seriously obese people nor Ozempic or Rybelsus, drugs to help diabetics manage their disease
There's a question I haven't been able to answer in my research: by how much exactly do these drugs increase GLP-1, and specifically how much more do they activate GLP-1 receptors
Das ist individuell unterschiedlich
A pediatrician, he works at the University of California, Irvine